Navigation Links
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
Date:6/26/2009

- Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit -

GENEVA, and REDWOOD CITY, Calif., June 26 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer recommended for the first time that validated multigene assays, such as Oncotype DX(R), should be considered as an adjunct to standard measures in helping determine chemotherapy benefit for early-stage breast cancer patients. These new treatment guidelines, published online in the cancer journal, Annals of Oncology, represent a significant advancement for the role of validated molecular diagnostics in breast cancer treatment planning and selection in Europe.

According to the guidelines, the threshold for recommending chemotherapy in treating estrogen receptor (ER) positive, HER2-negative breast cancer is difficult to define. Clinical research in the United States and other countries shows that information obtained from multigene assays, including Oncotype DX, leads to a change in treatment decisions in approximately 30 percent of cases. Physicians from more than 40 countries currently use Oncotype DX to predict the likelihood of chemotherapy benefit as well as the likelihood of recurrence for patients with early stage breast cancer, in order to make individualized treatment decisions about the addition of chemotherapy to hormonal therapy.

Oncotype DX was launched in the United States in 2004 where is has since been widely adopted as standard of care for treating early-stage breast cancer. Oncotype DX is the only validated multigene expression assay recommended in both the American Society of Clinical Oncology
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Lethality of H1N1 Influenza Virus Increasing According to Latest Analysis of Virus Peptide Genomic Data
2. Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease
3. Sirius Genomics Announces 2009 Board of Directors
4. Quest Diagnostics to Present Genomic Studies Related to New Testing Techniques for Leukemia and Prostate Cancer at 2009 ASCO Meeting
5. Agendia Opens CLIA-Registered U.S. Genomics Laboratory
6. Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data
7. Transgenomic, Inc. Announces Appointment of New Board Members
8. AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1
9. Transgenomic, Inc. Reports First Quarter 2009 Results
10. Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
11. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Research and Markets ... DNA Diagnostics Market (Product types, Application, Technology, End ... Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, ... to their offering. This new ... end users and Geography) Global Size, Industry Analysis, ...
(Date:10/22/2014)... 2014 The Americas Inorganic Refrigerants ... market in Americas with analysis and forecast of ... Americas Inorganic Refrigerants Market report, to get an ... provides a glimpse of the segmentation in the ... various tables and figures. , http://www.micromarketmonitor.com/market/americas-inorganic-refrigerants-4191654241.html ...
(Date:10/22/2014)... October 21, 2014 Shimadzu Scientific Instruments ... data tool for the pain management and clinical markets. ... processing and review by allowing users to highlight and ... , QuantAnalytics allows analysts to filter results by ... data processing by eliminating the need to sift through ...
(Date:10/22/2014)... 22, 2014 WriteResult, LLC – ... has been working with a team of researchers from ... Farms Community Farming Collaborative to provide electronic questionnaire data ... The study, which started in May, aims to evaluate ... participants weekly exposure to and participation in urban agriculture ...
Breaking Biology Technology:Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 2The Americas Inorganic Refrigerants Market is estimated to grow to $71.6 million by 2018 - New Report by MicroMarket Monitor 3Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3
... offers multiple diagnostic modalities on a single system ... ... physicians and administrators, SAN DIEGO, March 28 Volcano ... intravascular,ultrasound (IVUS), functional measurement (FM) and Optical Coherence,Tomography (OCT) products ...
... Vical Incorporated,(Nasdaq: VICL ) today announced the ... 27, 2008, of a New Drug Application (NDA) ... for its angiogenesis,product candidate, Collategene, for treatment of ... deliver a gene encoding hepatocyte,growth factor (HGF), a ...
... Ill. Scientists have developed a new form of ... shapes such as spheres, body parts and aircraft wings, ... types of extreme mechanical deformations, without a reduction in ... used in such applications because it is intrinsically brittle ...
Cached Biology Technology:Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 2Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 3Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 4Volcano Announces U.S. and European Launch of Rotational IVUS and Integrated FFR 5Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product 2Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product 3Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product 4Foldable and stretchable, silicon circuits conform to many shapes 2Foldable and stretchable, silicon circuits conform to many shapes 3
(Date:10/22/2014)... BEDFORD, Mass., Oct. 21, 2014 Aware, Inc. (NASDAQ: ... and services, today reported financial results for its third quarter ... quarter of 2014 was $6.0 million, an increase of 40% ... Operating income in the third quarter of 2014 was $4.1 ... 2013. Higher operating income in the current three month period ...
(Date:10/18/2014)... with undiagnosed, suspected genetic conditions, a certain type of ... diagnostic yield than traditional molecular diagnostic methods, according to ... is being released to coincide with the American Society ... sequences the protein­coding region of the genome (the complete ... cell or organism), has been rapidly applied in research ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Emergency aid for overdoses 2Emergency aid for overdoses 3
... GenWay Clinical Laboratory, a US-based diagnostic company with ... in their laboratory and now offers this testing service. ... a small blood sample from the patient in order ... their serum. This unique and proprietary test formula ...
... researchers have so far won 19 grants worth a total ... American Recovery and Reinvestment Act. The grants range from ... could produce biological hydrocarbons for biofuels to $600,000 for a ... how the Ebola virus can inhibit a body,s antiviral response. ...
... Japanese research group led by Professor Junichi Nabekura in ... after cerebral stroke in one side of the mouse ... circuits to recuperate from damaged neural function. The Japan ... report their finding in Journal of Neuroscience , ...
Cached Biology News:Iowa State faculty attract $4.8 million in American Recovery and Reinvestment Act grants 2Iowa State faculty attract $4.8 million in American Recovery and Reinvestment Act grants 3Iowa State faculty attract $4.8 million in American Recovery and Reinvestment Act grants 4
... Virus Reverse Transcriptase (M-MLV RT) is an RNA-dependent ... synthesis with long messenger RNA templates (>5kb). The ... of M-MLV and consists of a single subunit ... H activity of M-MLV RT is weaker than ...
... 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) is ... (8-iso PGF2α), in rabbits, monkeys and ... product of non-specific lipid peroxidation. In ... 8-isoprostane is converted primarily to metabolites ...
... The European Collection of Cell Cultures ... the West of the West of England, ... for the quality control of HER2, oestrogen ... of paraffin wax sections of formalin fixed, ...
kismet (dK-20)...
Biology Products: